The HealthSignals Brief
Biweekly intelligence on pharma & healthcare in Latin America. Regulatory moves, deals, and market signals — in 5 minutes, every other week.
THE HEALTHSIGNALS BRIEF
A fortnightly PDF compiling our analysis on pharma, medical devices, health policy and epidemiology across Latin America and the United States.
You're in. The next Brief lands in your inbox.
What you get
- Regulatory radar: COFEPRIS, ANVISA, ANMAT and FDA moves that affect Latin American markets
- Deal flow: M&A, licensing, and market-entry signals across pharma and healthcare
- Market signals: the trends behind the headlines, curated from hundreds of sources
Built for decision-makers at pharma companies, CROs, health agencies, and investors covering the region.
